Testing effectiveness (Phase 2)Study completedNCT03753763What this trial is testingSafinamide for Multiple System Atrophy (MSA)Who this might be right forMultiple System Atrophy Zambon SpA 49
Very early researchLooking for participantsNCT06765733What this trial is testingThe Study of Safety and Preliminary Efficacy of Aleeto in Patients With MultIple System AtrophyWho this might be right forMultiple System Atrophy - Parkinsonian Subtype (MSA-P)Multiple System Atrophy, MSA Beijing Tiantan Hospital 20
Not applicableEnrolling By InvitationNCT03655223What this trial is testingEarly Check: Expanded Screening in NewbornsWho this might be right forSpinal Muscular AtrophyFragile X SyndromeFragile X - Premutation+182 more RTI International 30,000
Not applicableStudy completedNCT06204575What this trial is testingFocused Ultrasound Thalamotomy for Tremor Relief in Atypical ParkinsonismWho this might be right forAtypical ParkinsonismDementia With Lewy BodiesMultiple System Atrophy, MSA Rambam Health Care Campus 8
Testing effectiveness (Phase 2)Study completedNCT00750867What this trial is testingTreatment of Multiple System Atrophy Using Intravenous ImmunoglobulinsWho this might be right forMultiple System Atrophy University of Massachusetts, Worcester 9
Testing effectiveness (Phase 2)Study completedNCT02388295What this trial is testingAZD3241 PET MSA Trial, Phase 2, Randomized,12 Week Safety and Tolerability Trial With PET in MSA PatientsWho this might be right forMultiple System Atrophy, MSA AstraZeneca 59
Not applicableTemporarily Not AvailableNCT07238062What this trial is testing"An Intermediate Size Patient Population Expanded Access Protocol to Evaluate the Safety and Efficacy of Allogeneic HB-adMSCs (Hope Biosciences - Adipose Derived Mesenchymal Stem Cells) for the Treatment of Multiple System Atrophy."Who this might be right forMultiple System Atrophy Hope Biosciences Research Foundation